About PCSS-O

What Providers' Clinical Support System for Opioid Therapies Offers:

This consortium of major stakeholders and constituency groups with interests in safe and effective use of opioid medications offers extensive experience in training and colleague support in the treatment of substance use disorders and specifically, opioid dependence treatment, as well as experience in the interface of pain and opioid misuse. In collaboration with our partners, educational products are available at no charge to those wishing to obtain additional knowledge on the safe and effective treatment of chronic pain with opioids and safe and effective treatment of opioid dependence.  Our focus will be on opioid medications without a Risk Evaluation and Mitigation Strategy (REMS) for example, immediate release, short-acting opioid medications.

We offer: 

  1. Our extensive network of member organizations who serve in diverse communities, both urban and rural, and who provide services to clinicians with patients from many cultures and backgrounds, all of whom will benefit from the educational programs offered in the PCSS-O
  2. Resources to deliver and disseminate trainings in safe and effective use of opioid medications 
  3. Resources to build a colleague support system

A brief description of each of the consortium organizations follows:

American Academy of Addiction Psychiatry (AAAP): is the lead organization for this project. With a membership of nearly 1,000 addiction psychiatrists, all with interests in clinical care and education; AAAP has been a key national organization involved with training and mentoring of physicians providing treatment for substance use disorders. AAAP has taken the lead in developing innovative approaches to training that have seen widespread success particularly in the area of office-based treatment of opioid dependence. AAAP developed the first 8-hour, online buprenorphine training leading to waiver eligibility. As one of five organizations authorized by DATA 2000 to train physicians in becoming waivered so that they may offer office-based treatment of opioid dependence, AAAP has trained over 8000 physicians.  The development of educational offerings for PCSS-O will build upon experiences gained in educational tool development to date, much of which is being utilized successfully in the Physicians' Clinical Support System-Buprenorphine. AAAP also leads the Education Committee for PCSS-O including development of web-based and webinar offerings, Tool Kit development, and virtual patient scenarios.

American Dental Association (ADA): Founded in 1859; American Dental Association is the oldest and largest national dental society in the world. ADA has grown to become the leading source of oral health related information for dentists and their patients. There are over 157,000 ADA members from all 50 states, the District of Columbia and Puerto Rico. ADA works to advance the dental profession on the national, state and local level with an extensive network of state and local dental societies which provide ongoing educational activities and advocacy on the national, state and local levels. ADA has been involved with the ongoing education of dental health practitioners on safe and effective methods of pain control and sedation in dental practice as well as ongoing updates regarding safe use of opioid analgesics with dissemination through extensive website information, ADA News, and periodic webinars.  ADA has available dentists with expertise in pain management who will work on this project to provide the educational tools from this project to its large constituency.

American Medical Association (AMA): is the leading medical association in the country with a membership of 200,000 physicians, 54 geographic medical societies, 109 national specialty societies, 2 professional interest medical associations, and 5 uniformed federal services.  AMA has extensive experience in health system capacity building, implementation of evidence-based clinical and community interventions, and promoting best practices to improve health.  It provides involvement opportunities, access to clinical research and professional publications, and practice management tools.  AMA policy supports the training of medical students and physicians on opioid prescribing to minimize diversion and appropriately treat patients. AMA developed a 12 module CME course on Pain Management, supported the launch of NIDAMED and co-sponsored a national symposium on the intersection of "Pain, Opioids, and Addiction."

American Osteopathic Academy of Addiction Medicine (AOAAM): is a branch of the American Osteopathic Association dedicated to improving the understanding of addiction as a disease, committed to attaining science-based core competencies in prevention, assessment, and treatment planning by all Osteopathic Physicians, with a leadership voice in the Osteopathic Profession for sound public policy associated with the problems of substance use disorders.  AOAAM has a strong grass-roots network of providers serving in both underserved urban and rural areas.  AOAAM also has established a close association with the majority of osteopathic medical schools in an attempt to ensure core competencies in addiction medicine are being taught. The osteopathic profession makes up 8% of physicians in the U.S., however, because of the emphasis on family practice it is estimated 20% of primary care in this country is delivered by osteopathic physicians.  As part of our consortium for Physicians' Clinical Support System-Buprenorphine (PCSS-B), AOAAM has delivered numerous trainings in community settings both urban and rural.  Because of AOAAM's wealth of experience with outreach and dissemination activities related to its work in primary care and substance use disorders, one of its important roles in PCSS-O will be to head the Dissemination Committee for training activities.  The success of a project such as PCSS-O depends on steadfast attention to dissemination and outreach to prescribers to get them involved with educational activities related to safe opioid prescribing and to keep them engaged; keep them coming back for more trainings, use of the peer support system to get the information they need to safely treat chronic pain and/or opioid dependence. 

American Psychiatric Association (APA): founded in 1844, is the world's largest psychiatric organization.  It is a medical specialty society representing 36,000 psychiatric physicians from the U.S. and around the world. Its member physician's work together to ensure humane care and effective treatment for all persons with mental disorders; including intellectual developmental disorders and substance use disorders.  APA members are primarily medical specialists who are psychiatrists or in the process of becoming psychiatrists.  One of the means by which APA maintains a grassroots presence in local communities is by the work of its State Associations and District Branches.  These organizations maintain regular contact with association members and provide local educational opportunities, as well as opportunities for networking and regular interaction of members.

American Society for Pain Management Nursing (ASPMN): is a professional nursing organization founded in 1990 with 1800 members including registered nurses, nurse practitioners, clinical nurse specialists, and researchers.  ASPMN's mission is to advance and promote optimal nursing care for people affected by pain by promoting best nursing practices.  This is accomplished through education, standards, advocacy, and research.  Through the American Nursing Credentialing Center, ASPMN members are encouraged to become certified in Pain Management Nursing.  In 2010, ASPMN published the Core Curriculum for Pain Management Nursing (Ed II).  ASPMN's official journal is Pain Management Nursing; a highly regarded peer-reviewed journal with national and international papers written by experts in the field. 

International Nurses Society on Addictions (IntNSA): is a professional specialty organization founded in 1975 for nurses committed to the prevention, intervention, treatment, and management of addictive disorders.  IntNSA's mission is to advance excellence in nursing care for the prevention and treatment of addictions for diverse populations across all practice settings.  The diversity of IntNSA's 700 members is reflective of the nurses who care for individuals, families, and populations impacted by the continuum of alcohol and other drug use, abuse, and other addiction.  With the American Nurses Association, IntNSA has established the Scope and Standards of Addictions Nursing Practice, a foundation upon which the certifications in addictions nursing (Certified Addictions Registered Nurse [CARN] and CARN-Advanced Practice [CARN-AP]) have been built.  IntNSA contributes to the advancement of knowledge in the specialty of addictions nursing via the Journal of Addictions Nursing, the official journal of IntNSA.  This premier journal is published quarterly and includes original papers, Continuing Education features, and regular columns that focus on clinical topics, policy, and nursing roles.  As such, IntNSA has a cadre of experts readily available to disseminate knowledge to other professional and community groups.